(NBY) |
| 0 (0%) 10-10 07:12 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 3.96 |
| Resistance 1: | 2.89 |
| Pivot price: | 1.70 |
| Support 1: | 1.16 |
| Support 2: | 0.97 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 2.300 |
| Book Value | 0.730 |
| PEG Ratio | 0.00 |
| Gross Profit | 1.113 |
| Profit Margin (%) | 33.98 |
| Operating Margin (%) | -57.85 |
| Return on Assets (ttm) | -65.3 |
| Return on Equity (ttm) | -413.8 |
Company news
Thu, 09 Oct 2025
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement By Investing.com - Investing.com Canada
Thu, 09 Oct 2025
NovaBay Pharma Enters Securities Purchase Agreement - TipRanks
Tue, 23 Sep 2025
NovaBay Pharmaceuticals, Inc. (NBY) Declares $0.80 Special Dividend, Boosting Shareholder Value - Yahoo Finance
Sat, 06 Sep 2025
NovaBay Pharmaceuticals Faces Growth Challenges Amidst Financial Instabilities - StocksToTrade
Wed, 27 Aug 2025
Why Is NovaBay Pharma Stock (NBY) Up Today? - TipRanks
Tue, 26 Aug 2025
NovaBay (NBY) Announces Special Dividend and Securities Agreemen - GuruFocus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
